Motion | Filed: October 06, 2026
| Entered: October 06, 2026
In Re: Oral Phenylephrine Marketing and Sales Practices Litigation
Fraud or Truth-In-Lending | New York Eastern
Amend/Correct/Supplement
First MOTION to Amend/Correct/Supplement 200 Amended Complaint,,,, Supplemental Complaint,,, by Plaintiffs. (Attachments: # 1 Memorandum in Support, # 2 Declaration of Jonathan D Selbin in Support, # 3 Exhibit 1 - Redlined Proposed Amended Complaint, # 4 Exhibit 2 - Clean Version of Proposed Amended Complaint, # 5 Exhibit A to Proposed Amended Complaint, # 6 Exhibit A (Contd.), # 7 Exhibit A (Contd.), # 8 Exhibit A (Contd.), # 9 Exhibit A (Contd.), # 10 Exhibit A (Contd.), # 11 Exhibit A (Contd.), # 12 Exhibit A (Contd.), # 13 Exhibit A (Contd.), # 14 Exhibit A (Contd.), # 15 Exhibit A (Contd.), # 16 Exhibit A (Contd.), # 17 Exhibit A (Contd.), # 18 Exhibit A (Contd.), # 19 Exhibit A (Contd.), # 20 Exhibit A (Contd.), # 21 Exhibit A (Contd.), # 22 Exhibit A (Contd.), # 23 Exhibit A (Contd.), # 24 Exhibit A (Contd.), # 25 Exhibit A (Contd.), # 26 Exhibit A (Contd.), #
Notice | Filed: September 29, 2026
| Entered: September 29, 2026
In Re: Oral Phenylephrine Marketing and Sales Practices Litigation
Fraud or Truth-In-Lending | New York Eastern
Notice of Appearance
NOTICE of Appearance by Jason Zarrow on behalf of Johnson & Johnson Consumer Inc., Kenvue Inc. (aty to be noticed) (Zarrow, Jason)